These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33100863)

  • 1. IL-18 and related function proteins associated with tuberculosis severity and screening for active TB among patients with non-mycobacterial community-acquired pneumonia (CAP).
    Wawrocki S; Seweryn M; Kielnierowski G; Rudnicka W; Druszczynska M
    Saudi J Biol Sci; 2020 Nov; 27(11):3035-3045. PubMed ID: 33100863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-18/IL-37/IP-10 signalling complex as a potential biomarker for discriminating active and latent TB.
    Wawrocki S; Seweryn M; Kielnierowski G; Rudnicka W; Wlodarczyk M; Druszczynska M
    PLoS One; 2019; 14(12):e0225556. PubMed ID: 31821340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-18, Functional IL-18 Receptor and IL-18 Binding Protein Expression in Active and Latent Tuberculosis.
    Wawrocki S; Kielnierowski G; Rudnicka W; Seweryn M; Druszczynska M
    Pathogens; 2020 Jun; 9(6):. PubMed ID: 32521630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
    Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
    Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    Sun Q; Wei W; Sha W
    PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of IL-2, IL-10, IL-17 and IP-10 as potent discriminative markers for active tuberculosis among pulmonary tuberculosis suspects.
    You E; Kim MH; Lee WI; Kang SY
    Tuberculosis (Edinb); 2016 Jul; 99():100-108. PubMed ID: 27450011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection.
    Wu J; Wang S; Lu C; Shao L; Gao Y; Zhou Z; Huang H; Zhang Y; Zhang W
    Tuberculosis (Edinb); 2017 Jan; 102():68-75. PubMed ID: 28061954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker.
    Borgström E; Andersen P; Atterfelt F; Julander I; Källenius G; Maeurer M; Rosenkrands I; Widfeldt M; Bruchfeld J; Gaines H
    PLoS One; 2012; 7(11):e43438. PubMed ID: 23144772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis.
    Niu WY; Wan YG; Li MY; Wu ZX; Zhang LG; Wang JX
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3329-33. PubMed ID: 24379064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Th1-cell immune responses for distinguishing active tuberculosis from non-active tuberculosis: A case-control study.
    Zhang L; Cheng X; Bian S; Song Y; Li Q; Gao M; Zhang Y; Shi X; Liu X
    PLoS One; 2017; 12(5):e0177850. PubMed ID: 28531231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
    Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
    J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of IFN-γ/IL-2 FluoroSpot assay for distinguishing active tuberculosis from non-active tuberculosis: A cohort study.
    Zhang L; Wan S; Ye S; Cheng X; Zhang Y; Shi X; Zhou B; Sun X; Liu X
    Clin Chim Acta; 2019 Dec; 499():64-69. PubMed ID: 31454491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis.
    Goletti D; Raja A; Ahamed Kabeer BS; Rodrigues C; Sodha A; Butera O; Carrara S; Vernet G; Longuet C; Ippolito G; Thangaraj S; Leportier M; Girardi E; Lagrange PH
    J Infect; 2010 Jul; 61(2):133-43. PubMed ID: 20470822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of HLA-DR on
    Luo Y; Xue Y; Tang G; Lin Q; Song H; Liu W; Yin B; Huang J; Wei W; Mao L; Wang F; Sun Z
    Front Immunol; 2021; 12():761209. PubMed ID: 34858413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.
    La Manna MP; Orlando V; Li Donni P; Sireci G; Di Carlo P; Cascio A; Dieli F; Caccamo N
    PLoS One; 2018; 13(3):e0192664. PubMed ID: 29543810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma assay in combination with tuberculin skin test are insufficient for the diagnosis of culture-negative pulmonary tuberculosis.
    Wlodarczyk M; Rudnicka W; Janiszewska-Drobinska B; Kielnierowski G; Kowalewicz-Kulbat M; Fol M; Druszczynska M
    PLoS One; 2014; 9(9):e107208. PubMed ID: 25221998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
    Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
    Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence setting.
    Clifford V; Tebruegge M; Zufferey C; Germano S; Forbes B; Cosentino L; Matchett E; McBryde E; Eisen D; Robins-Browne R; Street A; Denholm J; Curtis N
    Tuberculosis (Edinb); 2019 Jan; 114():91-102. PubMed ID: 30711163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a whole-blood chemiluminescent immunoassay of IFN-γ, IP-10, and MCP-1 for diagnosis of active pulmonary tuberculosis and tuberculous pleurisy patients.
    Liang Y; Wang Y; Li H; Yang Y; Liu J; Yu T; Wu X
    APMIS; 2016 Oct; 124(10):856-64. PubMed ID: 27523388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.